Search Medical Condition
Please enter condition
Please choose location from dropdown

Lusaka, Zambia Clinical Trials

A listing of Lusaka, Zambia clinical trials actively recruiting patients volunteers.

RESULTS

Found (27) clinical trials

Safety and Immune Response to a Clade C DNA HIV Vaccine

This study will evaluate the safety, tolerability, and immunogenicity to DNA-HIV-PT123 (an HIV clade C DNA vaccine) and to Bivalent Subtype C gp120/MF59 in healthy, HIV-uninfected adults. The study will enroll healthy, HIV-uninfected participants aged 18 to 40 years. Participants will be randomly assigned to one of 6 groups. Each ...

Phase

0.0 miles

Learn More »

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

The Zambian Ministry of Health (MoH) considers viral hepatitis a significant public health threat; however, there are limited representative data on HBV burden, risk factors, clinical significance, and interaction with co-infections and co-morbidities that are common in Zambia. In collaboration with the Central Statistical Office, MoH, and Centers for Disease ...

Phase N/A

0.0 miles

Learn More »

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Cholera is a life-threatening disease if prompt actions are not taken. The most recent estimates of the global burden of cholera estimate that there are more than 1.3 billion people at risk. Of which, 2.86 million (range: 1.3-4.0 million) will contract cholera and 95,000 (21,000-143,000) will die each year. A ...

Phase

0.0 miles

Learn More »

A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa

The primary purpose of this study is to assess the preventive vaccine efficacy (VE), safety and tolerability of a heterologous prime/boost regimen utilizing Ad26.Mos4.HIV and aluminum-phosphate adjuvanted Clade C gp140 for the prevention of Human Immuno Virus (HIV) infection in HIV-seronegative women residing in sub-Saharan Africa from confirmed HIV-1 infections ...

Phase

0.0 miles

Learn More »

Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part I

This study will compare the incidence of hypothermia during the first hour after birth in preterm/low birth weight infants randomized to receive WHO thermoregulation care and a plastic bag (without drying) covering the torso and lower extremities (control group) or WHO thermoregulation care and a plastic bag (without drying) covering ...

Phase N/A

0.0 miles

Learn More »

Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part II

Due to limited resources, hospitals in the developing world struggle to provide sufficient incubators and to maintain climate-controlled nurseries. Therefore, premature low birth weight infants continue to be at an increased risk of hypothermia throughout their hospitalizations. This study will compare the incidence of hypothermia in preterm/low birth weight infants ...

Phase N/A

0.0 miles

Learn More »

Maternal Newborn Health Registry

The purpose of the Global Network for Women's and Children's Health Research is to develop and test feasible, sustainable interventions to improve the outcome of women and children and to develop research capacity in resource-poor settings. Because most of the sites have weak health care systems, unacceptably high rates of ...

Phase N/A

0.0 miles

Learn More »

Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part III

Incubators in the developing world often lack humidifiers. The resting dry heat increases evaporative heat loss, the most prominent form of heat loss in premature infants due to their increased body surface area and immature stratum corneum. By potentially increasing humidity around the infants and decreasing evaporative heat losses, plastic ...

Phase N/A

0.0 miles

Learn More »

Zambian Prematurity Prevention Study

After consenting to study participation, women will complete a brief, interviewer-administered questionnaire. Detailed medical and obstetrical history will be collected. Participants will be provided standard of care. Blood, urine, and vaginal specimens will also be collected for the biorepository from those who consent to participate. Throughout the study, participants will ...

Phase N/A

0.0 miles

Learn More »

Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision Method

The objective of this clinical investigation is to provide the first and preliminary clinical data to study the safety and efficacy of male circumcision where the dry circumcision method is employed.

Phase

0.0 miles

Learn More »